GangaGen, Inc.   Report issue

For profit Phase 2
Founded: Palo Alto CA United States (2000)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2012
NCT01746654
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now